These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11126208

  • 1. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
    Molnár D, Török K, Erhardt E, Jeges S.
    Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
    Toubro S, Astrup AV, Breum L, Quaade F.
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
    [Abstract] [Full Text] [Related]

  • 3. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A, Breum L, Toubro S, Hein P, Quaade F.
    Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
    [Abstract] [Full Text] [Related]

  • 4. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
    Breum L, Pedersen JK, Ahlstrøm F, Frimodt-Møller J.
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
    [Abstract] [Full Text] [Related]

  • 5. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
    Toubro S, Astrup A, Breum L, Quaade F.
    Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
    [Abstract] [Full Text] [Related]

  • 6. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
    Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.
    Int J Obes Relat Metab Disord; 2002 May; 26(5):593-604. PubMed ID: 12032741
    [Abstract] [Full Text] [Related]

  • 7. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
    Daly PA, Krieger DR, Dulloo AG, Young JB, Landsberg L.
    Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S73-8. PubMed ID: 8384187
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
    Astrup A, Buemann B, Christensen NJ, Toubro S, Thorbek G, Victor OJ, Quaade F.
    Metabolism; 1992 Jul; 41(7):686-8. PubMed ID: 1619985
    [Abstract] [Full Text] [Related]

  • 10. Is an ephedrine caffeine treatment contraindicated in hypertension?
    Ingerslev J, Svendsen TL, Mørk A.
    Int J Obes Relat Metab Disord; 1997 Aug; 21(8):666-73. PubMed ID: 15481766
    [Abstract] [Full Text] [Related]

  • 11. Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.
    Bracale R, Petroni ML, Davinelli S, Bracale U, Scapagnini G, Carruba MO, Nisoli E.
    PLoS One; 2014 Aug; 9(6):e98244. PubMed ID: 24905629
    [Abstract] [Full Text] [Related]

  • 12. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
    Buemann B, Marckmann P, Christensen NJ, Astrup A.
    Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.
    Liu AG, Smith SR, Fujioka K, Greenway FL.
    Obesity (Silver Spring); 2013 Oct; 21(10):1991-6. PubMed ID: 23686786
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet. A randomized, placebo-controlled, double-blind trial].
    Quaade F, Astrup A, Breum L, Toubro S, Hein P.
    Ugeskr Laeger; 1992 Apr 27; 154(18):1258-63. PubMed ID: 1598695
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.
    Greenway FL.
    Obes Rev; 2001 Aug 27; 2(3):199-211. PubMed ID: 12120105
    [Abstract] [Full Text] [Related]

  • 19. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
    Malchow-Møller A, Larsen S, Hey H, Stokholm KH, Juhl E, Quaade F.
    Int J Obes; 1981 Aug 27; 5(2):183-7. PubMed ID: 7228474
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.